Search for: "Kaisa v. Chang" Results 1 - 20 of 73
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
On 17 April 2024, the Court of Appeal of the UPC handed down its decision concerning the language of proceedings in the (undoubtedly ground-breaking) case of Curio Bioscience v 10x Genomics. [read post]
29 Dec 2018, 6:30 am by Sara Moran
However, as the Court of Appeal upheld the first instance Court’s decision that the patent was invalid, this ultimately did not change the effect of the first instance judgment. [read post]
31 Aug 2019, 3:31 am by Sara Moran
Sara MoranThe Court rejected a claim that a new action brought by the claimant asserting additional patents from its portfolio was an abuse of process, finding that a radical change in position by the defendant had driven the need for the claimant to bring an action on other patents. [read post]
2 Feb 2021, 8:04 am by Laurence Lai (Simmons & Simmons LLP)
Perhaps the most significant change coming from the harmonisation is in F-V, 3.3.1. [read post]
1 Feb 2022, 7:01 am by Laurence Lai (Simmons & Simmons LLP)
Honourable mentions F-V, 3.2.4 – new example of lack of unity in claims with multiple dependencies. [read post]
14 Nov 2023, 4:18 am by Chloe Dickson (Bristows)
  The IQOS ILUMA’s use of the Curie point or having the heater in the consumable did not change the way in which this result was achieved. [read post]
27 Mar 2023, 8:18 am by Nicholas Round (Bristows)
On 16 March 2023, the High Court of England and Wales handed down its judgment following the FRAND trial in InterDigital v Lenovo. [read post]
21 Jul 2022, 8:20 am by Brian Cordery (Bristows)
The law in this regard was summarised by Arnold J in Jarden Consumer Solutions (Europe) Ltd v SEB SA [2014] EWHC 445 (Pat) at [103]: “[103] As Kitchin LJ and Sir Robin Jacob said in their joint judgment in Gedeon  Richter plc v Bayer Pharma AG[2012] EWCA Civ 235, [2013] Bus LR D17 at [61], ‘it is trite law that… the older (from the priority date of a patent under attack) a piece of prior art said to render a patent obvious, the harder it is to show… [read post]
On 25 June 2021 Meade J handed down his decision in the second of a series of trials listed as part of the Optis v Apple UK action ([2021] EWHC 1739 (Pat); a link the judgment is here). [read post]
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
17 Sep 2019, 4:14 am by Brian Cordery
Michele Wales (InHouse Patent Counsel, US) provided the immediate contrast: whilst, once upon a time, functional claims were acceptable in the US, the 2017 decision of the Federal Circuit in Amgen v Sanofi changed all that. [read post]
18 Apr 2019, 4:47 am by Brian Cordery
In doing so, the Judge relied on several authorities including the judgment of Popplewell J in Thai-Lao Lignite (Thailand) v Government of Lao [2013]. [read post]
6 Feb 2024, 7:17 am by Brian Cordery (Bristows)
Was it the intention of the legislators to permit patentees the ability to so change the fundamental nature of a European Patent and retrospectively? [read post]
Does there need to be legislative change to address the role of Artificial Intelligence in the Australian patents scheme? [read post]
8 Apr 2021, 4:59 am by Roya Ghafele (OxFirst)
Cases such as Conversant vs ZTE/Huawei, Philips vs TCL, TQ Delta v ZyXel or Optis v Apple pertain equally to the licensing of standard essential patents. [read post]